Medical Transcription Billing, Corp. (MTBC) Given New $2.75 Price Target at Chardan Capital

Medical Transcription Billing, Corp. (NASDAQ:MTBC) had its price objective raised by Chardan Capital from $2.25 to $2.75 in a research note released on Tuesday morning. Chardan Capital currently has a buy rating on the technology company’s stock.

MTBC has been the topic of several other reports. ValuEngine downgraded Medical Transcription Billing, Corp. from a hold rating to a sell rating in a research note on Monday, October 2nd. Zacks Investment Research downgraded Medical Transcription Billing, Corp. from a hold rating to a sell rating in a research note on Tuesday, October 10th.

Shares of Medical Transcription Billing, Corp. (NASDAQ:MTBC) traded down $0.07 during trading hours on Tuesday, hitting $2.40. The stock had a trading volume of 321,500 shares, compared to its average volume of 1,218,755. Medical Transcription Billing, Corp. has a twelve month low of $0.29 and a twelve month high of $5.44. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.01.

ILLEGAL ACTIVITY NOTICE: “Medical Transcription Billing, Corp. (MTBC) Given New $2.75 Price Target at Chardan Capital” was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.themarketsdaily.com/2017/11/15/medical-transcription-billing-corp-mtbc-given-new-2-75-price-target-at-chardan-capital.html.

In related news, President Stephen Andrew Snyder sold 50,000 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $3.18, for a total transaction of $159,000.00. Following the transaction, the president now directly owns 106,000 shares in the company, valued at approximately $337,080. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 53.50% of the stock is owned by insiders.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply